Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos) – Associated distinct purpuric subtype of toxic erythema of chemotherapy: A retrospective review of 54 patients Research Letter

  

Authors:	Stoll, J. R.; Battle, L.; Moy, A.; Dusza, S. W.; Park, J. H.; Tallman, M. S.; Taylor, J.; Markova, A.
Title:	Liposomal cytarabine and daunorubicin (CPX-351/Vyxeos) – Associated distinct purpuric subtype of toxic erythema of chemotherapy: A retrospective review of 54 patients
Journal Title:	Journal of the American Academy of Dermatology
Volume:	86
Issue:	1
ISSN:	0190-9622
Publisher:	Mosby Elsevier
Date Published:	2022-01-01
Start Page:	232
End Page:	234
Language:	English
DOI:	10.1016/j.jaad.2021.01.096
PUBMED:	33539850
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85102742018&doi=10.1016%2fj.jaad.2021.01.096&partnerID=40&md5=c21381b57532e63c949b4b53e0c441b0
Notes:	Article -- Export Date: 3 January 2022 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/191805